Contents
Robert B. Tattersall
K. George M.M. Alberti
Lars C. Stene, Valma Harjutsalo, Elena Moltchanova & Jaakko Tuomilehto
Ronald C.W. Ma & Peter C.Y. Tong
Mohammed K. Ali, Mary Beth Weber & K.M. Venkat Narayan
Peter M. Jones & Shanta J. Persaud
Xuxia Wu & W. Timothy Garvey
George A. Bray
Ahmed J. Delli, Helena Elding Larsson, Sten-A. Ivarsson & Ake Lernmark
Alice P.S. Kong & Juliana C.N. Chan
Mazen Alsahli & John E. Gerich
Hannele Yki-Jarvinen
Martine Vaxillaire & Philippe Froguel
Adrian Vella & Robert A. Rizza
Hans Hauner
Angus Jones & Andrew T. Hattersley
Neil J.L. Gittoes, John Ayuk & Robin E. Ferner
Neil A. Hanley
Ranjit Unnikrishnan & Viswanathan Mohan
Ee Lin Lim & Roy Taylor
Richard I.G. Holt & Barry J. Goldstein
Carole Mensing & Barbara Eichorst
Monika Toeller
Jane E. Yardley, Angela Alberga, Glen P. Kenny & Ronald J. Sigal
Brian M. Frier & Mark W.J. Strachan
Andrew J. Farmer
Bernard M.Y. Cheung & Robin E. Ferner
Stephen Gough & Parth Narendran
Howard Wolpert & Judy Shih
Clifford J. Bailey & Andrew J. Krentz
Jens Juul Holst, Sten Madsbad & Ole Schmitz
Joseph A. Aloi & Anthony L. McCall
Maggie Sinclair Hammersley & June James
Philip E. Cryer
Troels Krarup Hansen & Niels Møller
Ferdinando Giacco & Michael Brownlee
Peter H. Scanlon
Sally M. Marshall & Allan Flyvbjerg
Dan Ziegler
Riccardo Candido, Mark E. Cooper & Karin A.M. Jandeleit-Dahm
Peter M. Nilsson
Adie Viljoen & Anthony S. Wierzbicki
Inga S. Thrainsdottir & Lars Ryden
Colum F. Amory & Jesse Weinberger
Henrik H. Sillesen
Andrew J.M. Boulton
David Price
Adil E. Bharucha & Michael Camilleri
Graham R. Sharpe & Paul D. Yesudian
Andrew Grey & Nicola Dalbeth
Christopher M. Ryan
Clive S. Cockram & Nelson Lee
Christine Chan & Marian Rewers
Debbie Kralik & Maria Kambourakis
Anne Dornhorst & Anita Banerjee
Alan J. Sinclair
Robert C. Peveler & Richard I.G. Holt
Jane Overland, Margaret McGill & Dennis K. Yue
Wing-Yee So & Juliana C.N. Chan
Naomi S. Levitt, Bob Mash, Nigel Unwin, Jean Claude Mbanya, Jae-Hyoung Cho & Kun-Ho Yoon
Helena Elding Larsson, Ahmed J. Delli, Sten-A. Ivarsson & Ake Lernmark
Clifford J. Bailey
Shuibing Chen, Jayaraj Rajagopal, Qiao Zhou & Douglas A. Melton
Angela Koh, Peter Senior & A.M. James Shapiro
Andreea R. Barbu & Nils Welsh
Robert A. Gabbay & Alan M. Adelman
We dedicate this book to all people living with diabetes and the healthcare professionals who look after them. We would also like to dedicate this book to our families without whose support and encouragement the book would never have been finished.
This edition first published 2010. © 1991, 1997, 2003, 2010 by Blackwell Publishing Ltd
Blackwell Publishing was acquired by John Wiley & Sons in February 2007. Blackwell’s publishing program has been merged with Wiley’s global Scientific, Technical and Medical business to form Wiley-Blackwell.
Registered office: John Wiley & Sons Ltd, The Atrium, Southern Gate, Chichester, West Sussex, PO19 8SQ, UK
Editorial offices: | 9600 Garsington Road, Oxford, OX4 2DQ, UK |
111 River Street, Hoboken, NJ 07030-5774, USA | |
The Atrium, Southern Gate, Chichester, West Sussex, PO19 8SQ, UK |
For details of our global editorial offices, for customer services and for information about how to apply for permission to reuse the copyright material in this book please see our website at .
The right of the author to be identified as the author of this work has been asserted in accordance with the Copyright, Designs and Patents Act 1988.
All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, except as permitted by the UK Copyright, Designs and Patents Act 1988, without the prior permission of the publisher.
Wiley also publishes its books in a variety of electronic formats. Some content that appears in print may not be available in electronic books.
Designations used by companies to distinguish their products are often claimed as trademarks. All brand names and product names used in this book are trade names, service marks, trademarks or registered trademarks of their respective owners. The publisher is not associated with any product or vendor mentioned in this book. This publication is designed to provide accurate and authoritative information in regard to the subject matter covered. It is sold on the understanding that the publisher is not engaged in rendering professional services. If professional advice or other expert assistance is required, the services of a competent professional should be sought.
The contents of this work are intended to further general scientific research, understanding, and discussion only and are not intended and should not be relied upon as recommending or promoting a specific method, diagnosis, or treatment by physicians for any particular patient. The publisher and the author make no representations or warranties with respect to the accuracy or completeness of the contents of this work and specifically disclaim all warranties, including without limitation any implied warranties of fitness for a particular purpose. In view of ongoing research, equipment modifications, changes in governmental regulations, and the constant flow of information relating to the use of medicines, equipment, and devices, the reader is urged to review and evaluate the information provided in the package insert or instructions for each medicine, equipment, or device for, among other things, any changes in the instructions or indication of usage and for added warnings and precautions. Readers should consult with a specialist where appropriate. The fact that an organization or Website is referred to in this work as a citation and/or a potential source of further information does not mean that the author or the publisher endorses the information the organization or Website may provide or recommendations it may make. Further, readers should be aware that Internet Websites listed in this work may have changed or disappeared between when this work was written and when it is read. No warranty may be created or extended by any promotional statements for this work. Neither the publisher nor the author shall be liable for any damages arising herefrom.
ISBN: 9781405191814
A catalogue record for this book is available from the British Library.
Library of Congress Cataloging-in-Publication Data
Textbook of diabetes. – 4th ed./ edited by Richard I.G. Holt … [et al.]. p.; cm.
Includes bibliographical references and index.
ISBN 978-1-4051-9181-4 (hardback : alk. paper)
1. Diabetes. I. Holt, Richard I.G.
[DNLM: 1. Diabetes Mellitus. WK 810 T355 2010]
RC660.T467 2010
616.4’62–dc22
2010013907
Alan M. Adelman MS, MD
Professor of Family and Community Medicine, Vice Chair for Academic Affairs and Research, Penn State Milton S. Hershey Medical Center, Penn State College of Medicine, Hershey, PA, USA
Angela Alberga MSc
Faculty of Health Sciences, University of Ottawa and Ottawa Hospital Research Institute, Ottawa, Ontario, Canada
K. George M.M. Alberti DPhil, FRCP
Senior Research Fellow, Imperial College, London; Emeritus Professor of Medicine, University of Newcastle, Newcastle, UK
Mohammed K. Ali MBChB, MSc
Assistant Professor, Hubert Department of Global Health, Rollins School of Public Health, Global Diabetes Research Center, Emory University, Atlanta, GA, USA
Joseph A. Aloi MD
Associate Professor of Internal Medicine, The Strelitz Diabetes Center for Endocrine and Metabolic Disorders, Eastern Virginia Medical School, Norfolk, VA, USA
Mazen Alsahli MD
Professor of Medicine, University of Rochester School of Medicine, Rochester, NY, USA
Colum F. Amory MD, MPH
Mount Sinai School of Medicine, New York, NY, USA
John Ayuk MD
Centre for Endocrinology, Diabetes and Metabolism, University of Birmingham and Queen Elizabeth Hospital Birmingham, Birmingham, UK
Clifford J. Bailey PhD, FRCP(Edin), FRCPath
Professor in Clinical Science and Head of Diabetes Research, School of Life and Health Sciences, Aston University, Birmingham, UK
Anita Banerjee BSc, MBBS, MRCP
Obstetric Physician, Diabetes and Endocrinology, Princess Royal University Hospital, London, England UK
Andreea R. Barbu PhD
Department of Medical Cell Biology and Department of Medical Sciences, Uppsala University, Uppsala, Sweden
Adil E. Bharucha MD
Professor of Medicine, Division of Gastroenterology and Hepatology, Clinical Enteric Neuroscience Translational and Epidemiological Research Program, Mayo Clinic, Rochester, MN, USA
Andrew J.M. Boulton MD, DSc (Hon), FRCP
Professor of Medicine, University of Manchester and Manchester Royal Infirmary, Manchester, UK; Miller School of Medicine, University of Miami, Miami, FL, USA
George A. Bray MD, MACP
Boyd Professor, Pennington Biomedical Research Center, Louisiana State University, Baton Rouge, LA, USA
Michael Brownlee MD
Anita and Jack Saltz Professor of Diabetes Research, Albert Einstein College of Medicine, New York, NY, USA
Michael Camilleri MD
Atherton and Winifred W. Bean Professor, Professor of Medicine and Physiology, College of Medicine, Mayo Clinic and Clinical Enteric Neuroscience Translational and Epidemiological Research Program, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA
Riccardo Candido MD, PhD
Diabetic Centre, Trieste, Italy
Christine M. Chan MD
Barbara Davis Center for Childhood Diabetes, University of Colorado Denver, School of Medicine, Aurora, CO, USA
Juliana C.N. Chan MBChB MD FRCP
Professor of Medicine and Therapeutics, Director, Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, The Prince of Wales Hospital, Hong Kong SAR, China
Shuibing Chen PhD
Postdoctoral Fellow, Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA
Bernard M.Y. Cheung MD, PhD
Chair of Clinical Pharmacology and Therapeutics, Department of Clinical Pharmacology, University of Birmingham, Birmingham, UK
Jae-Hyoung Cho MD
Assistant Professor, Department of Endocrinology, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
Mark E. Cooper MD, PhD
Director, Danielle Alberti JDRF Centre for Diabetes Complications, Head, Vascular Division – Baker IDI Heart Research Institute, Melbourne, Australia
Philip E. Cryer MD
Irene E. and Michael M. Karl Professor of Endocrinology and Metabolism in Medicine, Washington University School of Medicine, St. Louis, MO, USA
Nicola Dalbeth MD, FRACP
Department of Medicine, University of Auckland, Auckland, New Zealand
Ahmed J. Delli MD, MPH
Clinical Research Center (CRC), Lund University, Department of Clinical Sciences/Diabetes and Celiac Disease, University Hospital MAS, Malmö, Sweden
Anne Dornhorst BSc, DM, FRCP, FRCPath
Consultant Physician, Honorary Senior Lecturer, Department of Medicine, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK
Barbara Eichorst MS,RD,CDE
Healthy Interactions Global Conversation Map™ Facilitator, Chicago, IL, USA
Andrew J. Farmer DM, FRCGP
University Lecturer, Department of Primary Health Care, University of Oxford, Oxford, UK
Robin E. Ferner MSc, MD, FRCP
Professor, West Midlands Centre for Adverse Drug Reactions, City Hospital, Birmingham, UK
Brian M. Frier BSc(Hons), MD, FRCPE, FRCPG
Professor, Department of Diabetes, Royal Infirmary of Edinburgh, Edinburgh, UK
Philippe Froguel MD, PhD
Institut de Biologie de Lille, Institut Pasteur de Lille, Lille, France; Section of Genomic Medicine, Imperial College London, London, UK
Robert A. Gabbay MD, PhD
Director, Penn State Institute for Diabetes and Obesity; Professor of Medicine and Molecular Medicine, Penn State College of Medicine; Director, Diabetes Program, Penn State Milton S. Hershey Medical Center, Hershey, PA, USA
W. Timothy Garvey MD
Butterworth Professor and Chair, Department of Nutrition Sciences; Director, UAB Diabetes Research and Training Center, University of Alabama at Birmingham; Birmingham Veterans Affairs Medical Center, Birmingham, AL, USA
John E. Gerich MD
Professor of Medicine, University of Rochester School of Medicine, Rochester, NY, USA
Ferdinando Giacco PhD
Postdoctoral Fellow, Diabetes Research and Training Center, Departments of Medicine and Endocrinology, Albert Einstein College of Medicine, New York, NY, USA
Neil J.L. Gittoes MD
Senior Lecturer in Medicine, Centre for Endocrinology, Diabetes and Metabolism, University of Birmingham and Queen Elizabeth Hospital Birmingham, Birmingham, UK
Steve Gough
Professor of Diabetes, Oxford Centre for Diabetes Endocrinology and Metabolism, University of Oxford; Consultant Physician, Churchill Hospital, Oxford, UK
Andrew Grey MD
Department of Medicine, University of Auckland, Auckland, New Zealand
Maggie Sinclair Hammersley MB, FRCP
Consultant Physician and Senior Lecturer, Nuffield Department of Medicine, University of Oxford, Oxford, UK
Neil A. Hanley MBChB, PhD
Professor of Medicine, Endocrinology and Diabetes Group, University of Manchester, Manchester, UK
Troels Krarup Hansen MD, PhD
Associate Professor, Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark
Valma Harjutsalo PhD
Folkhälsan Institute of Genetics, Folkhälsan Research Center, Biomedicum Helsinki; Diabetes Prevention Unit, National Institute of Health and Welfare, Helsinki, Finland; Division of Nephrology, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland
Andrew T. Hattersley MD
Diabetes and Vascular Medicine, Peninsula Medical School, Exeter, UK
Hans Hauner MD
Director, Else Kröner-Fresenius-Center for Nutritional Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
Jens Juul Holst MD, DMSc
Professor of Medical Physiology, Department of Biomedical Sciences, The Panum Institute, University of Copenhagen, Denmark
Sten–A. Ivarsson MD, PhD
Clinical Research Center (CRC), Lund University and Department of Clinical Sciences/Paediatric Endocrinology, University Hospital MAS, Malmö, Sweden
June James MSc, BA (Hons) Dip Nursing, NP RGN
Consultant Nurse in Diabetes, University Hospitals of Leicester, Leicester, UK
Karin A.M. Jandeleit-Dahm MD, PhD, FRACP
Baker IDI Heart and Diabetes Institute, Co-head, Diabetes Division; Professor of Medicine (Adjunct), Monash University, Melbourne, Australia
Peter Jones PhD
Professor of Endocrine Biology, King’s College London, London, UK
Angus Jones MBBS, MRCP
Diabetes and Vascular Medicine, Peninsula Medical School, Exeter, UK
Maria Kambourakis BSc(Hons)
Research Officer/Type 1 Diabetes Program Officer, Type 1 Diabetes Program, Diabetes Australia, Victoria, Australia
Glen P. Kenny MD
Ottawa Hospital Research Institute and Laboratory of Human Bioenergetics and Environmental Physiology, School of Human Kinetics, Faculty of Health Sciences, University of Ottawa, Ottawa, Ontario, Canada
Angela Koh MBBS (Singapore), MRCP (UK)
Assistant Professor, Department of Medicine (Endocrinology), Attending Physician, Clinical Islet Transplant Program, University of Alberta, Edmonton, Canada
Alice P.S. Kong MBChB, MRCP (UK), FRCP (Glasg)
Associate Professor, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China
Debbie Kralik PhD, RN
General Manager, Research and Strategy, Royal District Nursing Service, South Australia; Associate Professor, University of South Australia and University of Adelaide, Glenside, Australia
Andrew J. Krentz MD, FRCP
Formerly Southampton University Hospitals NHS Trust, Southampton, UK
Helena Elding Larsson MD, PhD
Clinical Research Center (CRC), Lund University; Department of Clinical Sciences/Paediatric Endocrinology, University Hospital MAS, Malmö, Sweden
Nelson Lee MD, FRCP(Edin)
Associate Professor, Head, Division of Infectious Diseases, Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China
Åke Lernmark PhD
Professor of Experimental Diabetes, Lund University/CRC, Department of Clinical Sciences, University Hospital MAS, Malmö, Sweden
Naomi S. Levitt MBChB, MD, FCP(SA)
Professor and Head of Division of Diabetic Medicine and Endocrinology, Department of Medicine, University of Cape Town and Groote Schuur Hospital, Cape Town, South Africa
Ee Lin Lim MRCP
Diabetes Research Group, Institute of Cellular Medicine, University of Newcastle, Newcastle upon Tyne, UK
Ronald C.W. Ma MB BChir, MRCP
Associate Professor, Division of Endocrinology and Diabetes, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince Of Wales Hospital, Hong Kong SAR, China
Sten Madsbad MD, DMSc
Professor of Diabetology, Department of Endocrinology, Hvidovre Hospital, Hvidovre, Denmark
Sally M. Marshall MD
Professor of Diabetes, Diabetes Research Group, Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK
Bob Mash MBChB, MRCGP, PhD
Professor, Division of Family Medicine and Primary Care, Stellenbosch University, Tygerberg, South Africa
Jean-Claude Mbanya MD, PhD, FRCP
Professor of Medicine and Endocrinology, Faculty of Medicine and Biomedical Sciences, University of Yaounde I, Yaounde, Cameroon
Anthony L. McCall MD, PhD
James M. Moss Professor of Diabetes in Internal Medicine, Diabetes and Hormone Center of Excellence, University of Virginia School of Medicine, Charlottesville, VA, USA
Margaret McGill RN, MSc(med)
Diabetes Centre, Royal Prince Alfred Hospital, Camperdown, Sydney, New South Wales, Australia
Douglas A. Melton
Thomas Dudley Cabot Professor in the Natural Sciences, Department of Stem Cell and Regenerative Biology; Harvard Stem Cell Institute; Investigator, Howard Hughes Medical Institute, Harvard University, Cambridge, MA, USA
Carolé R. Mensing RN, MA, CDE
Joslin Diabetes Center, Boston, MA, USA
Viswanathan Mohan MD, FRCP(UK), FRCP(Glasg), PhD, DSc, FNASc
Chairman and Chief Diabetologist, Dr. Mohan’s Diabetes Specialities Centre, WHO Collaborating Centre for Non Communicable Diseases Prevention and Control, IDF Centre of Education; President and Chief of Diabetes Research, Madras Diabetes Research Foundation, ICMR Advanced Centre for Genomics of Diabetes, Gopalapuram, Chennai, India
Niels Møller MD, DMSc
Professor, Department of Endocrinology and Internal Medicine, The Medical Research Laboratories, Arhus University Hospital, Arhus, Denmark
Elena Moltchanova PhD
Diabetes Unit, Department of Health Promotion and Chronic Disease Prevention, National Institute for Health and Welfare, Helsinki, Finland
K. M. Venkat Narayan MD, MSc, MBA, FRCP
Ruth and O.C. Hubert Professor of Global Health, Professor of Epidemiology and Medicine, Rollins School of Public Health, Emory University, Atlanta, GA, USA
Parth Narendran
Institute of Biomedical Research, The Medical School, University of Birmingham, Birmingham, UK
Peter M. Nilsson MD
Professor of Clinical Cardiovascular Research, Department of Clinical Sciences, Lund University, University Hospital, Malmö, Sweden
Jane Overland MPH, PhD
Nurse Practitioner, Diabetes Centre, Royal Prince Alfred Hospital, Campderdown, New South Wales, Australia; Clinical Associate Professor, The Faculty of Nursing and Midwifery, The University of Sydney, Sydney, Australia
Shanta J. Persaud PhD
Professor of Diabetes and Endocrinology, King’s College London, London, UK
Robert C. Peveler MA, DPhil, BM, BCh, FRCPsych
Clinical Neurosciences Division, School of Medicine, University of Southampton and Royal South Hants Hospital, Southampton, UK
David Price MD, FRCP
Department of Diabetes and Endocrinology, Morriston Hospital, Swansea, UK
Jayaraj Rajagopal
Center for Regenerative Medicine, Massachusetts General Hospital; Principal Investigator, Harvard Stem Cell Institute, Boston, MA, USA
Marian Rewers MD, PhD
Professor, Pediatrics and Preventive Medicine; Clinical Director, Barbara Davis Center for Childhood Diabetes, University of Colorado Denver, School of Medicine, Aurora, CO, USA
Robert A. Rizza MD
Professor of Medicine, Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic, Rochester, MN, USA
Christopher M. Ryan PhD
Professor of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA
Lars Rydén MD, FRCP, FESC, FACC, FAHA
Professor Emeritus, Cardiology Unit, Department of Medicine, Karolinska Institute, Stockholm, Sweden
Peter H. Scanlon MD, MRCOphth, DCH, FRCP
Consultant Ophthalmologist, Gloucestershire and Oxford Eye Units; Lecturer, Harris Manchester College, University of Oxford, Oxford, UK
Ole Schmitz MD, DMSc
Professor of Clinical Pharmacology, Department of Clinical Pharmacology, Aarhus University Hospital, Denmark
Peter A. Senior BMedSci, MBBS, PhD, MRCP(UK)
Clinical Islet Transplant Program, University of Alberta, Edmonton, Alberta, Canada
A.M. James Shapiro MD PhD DSc (Hon) FRCS(Eng) FRCSC MSM
Professor of Surgery, Director, Clinical Islet Transplant Program, AHFMR Scholar, University of Alberta, Edmonton, Canada
Graham R. Sharpe MBChB, BA, PhD, FRCP
Consultant Dermatologist, Department of Dermatology, Broadgreen Hospital, Liverpool, UK
Judy Shih MD, PhD
Joslin Diabetes Center, Boston, MA, USA
Ronald J. Sigal MD, MPH, FRCPC
Professor of Medicine, Cardiac Sciences, and Community Health Sciences, Faculties of Medicine and Kinesiology, The University of Calgary, Canada
Henrik H. Sillesen MD, DMSc
Head, Department of Vascular Surgery, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
Alan J. Sinclair MSc, MD, FRCP
Deputy Dean and Professor of Medicine, Bedfordshire and Hertfordshire Postgraduate Medical School; Geriatric and Diabetes Research Centre, University of Bedfordshire, Luton, UK
Wing-Yee So MBChB, MD, FRCP
Associate Consultant, Prince of Wales Hospital, Hong Kong SAR, China
Lars C. Stene PhD
Division of Epidemiology, Norwegian Institute of Public Health, Oslo, Norway; Oslo Diabetes Research Centre, Oslo University Hospital, Oslo, Norway
Mark W. J. Strachan MD, FRCP (Edin)
Consultant in Diabetes and Endocrinology, Metabolic Unit, Western General Hospital, Edinburgh, UK
Robert B. Tattersall MB, ChB, MD, FRCP
Emeritus Professor of Clinical Diabetes, University of Nottingham, Nottinghamshire, UK
Roy Taylor MD, FRCP
Professor of Medicine and Metabolism, and Director, Newcastle Magnetic Resonance Centre, Newcastle University, Newcastle upon Tyne, UK
Inga S. Thrainsdottir MD, PhD
Department of Cardiology, Landspitali University Hospital, Reykjavik, Iceland
Monika Toeller MD
German Diabetes Center, Heinrich Heine University Düsseldorf and Leibniz Center for Diabetes Research, Düsseldorf, Germany
Peter C.Y. Tong MBBS, PhD, BPharm, FRCP
Professor, Division of Endocrinology and Diabetes, Department of Medicine and Therapeutics, The Chinese University of Hong Kong and Prince Of Wales Hospital, Hong Kong SAR, China
Jaakko Tuomilehto MD, MA, PhD
Hjelt Institute, University of Helsinki and Diabetes Prevention Unit, Department of Health Promotion, National Institute for Health and Welfare, Helsinki, Finland, and South Ostrobothnia Central Hospital, Seinäjoki, Finland
Ranjit Unnikrishnan MD
Director and Consultant Diabetologist, Dr. Mohan’s Diabetes Specialities Centre, WHO Collaborating Centre for Non Communicable Diseases Prevention and Control and IDF Centre of Education, Madras Diabetes Research Foundation, ICMR Advanced Centre for Genomics of Diabetes, Chennai, India
Nigel Unwin BA, MSc, DM, FRCP, FFPH
Professor of Public Health and Epidemiology, Faculty of Medicine, University of the West Indies, Barbados
Martine Vaxillaire PharmD, PhD
Research Director at Pasteur Institute, CNRS 8090 and Pasteur Institute, Lille, France
Adrian Vella MD, FRCP(Edin)
Associate Professor of Medicine, Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic, Rochester, MN, USA
Adie Viljoen MBChB, MMed, FCPath (SA), FRCPath, MBA
Consultant Chemical Pathologist, Department of Chemical Pathology, Lister Hospital, Stevenage, UK
Mary Beth Weber MPH
Nutrition and Health Sciences Program, Graduate Division of Biological and Biomedical Sciences, Global Diabetes Research Center, Emory University, Atlanta, GA, USA
Jesse Weinberger MD
Department of Neurology, Mount Sinai School of Medicine, New York, NY, USA
Nils Welsh MD, PhD
Professor in Molecular Inflammation Research, Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden
Anthony S. Wierzbicki DM, DPhil, FRCPath, FAHA
Consultant Metabolic Physician and Chemical Pathologist, Guy’s and St Thomas Hospitals, London, UK
Howard Wolpert MD
Joslin Diabetes Center, Boston, MA, USA
Xuxia Wu MD, PhD
Department of Nutrition Sciences, University of Alabama at Birmingham, Birmingham, AL, USA
Jane E. Yardley MSc
Faculty of Health Sciences, University of Ottawa and Ottawa Hospital Research Institute, Ottawa, Ontario, Canada
Paul D. Yesudian MB, MD, MRCP
Consultant Dermatologist, Department of Dermatology, University of Liverpool and Broadgreen Hospital, Liverpool, UK
Hannele Yki-Järvinen MD, FRCP
Professor of Medicine, Department of Medicine, Division of Diabetes, University of Helsinki, Helsinki, Finland
Kun-Ho Yoon MD, PhD
Professor, Department of Endocrinology and Metabolism, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
Dennis K. Yue MBBS, FRACP, PhD
Diabetes Centre, Royal Prince Alfred Hospital; University of Sydney, Sydney, New South Wales, Australia
Qiao Zhou
Assistant Professor, Department of Stem Cell and Regenerative Biology, Principle Investigator, Harvard Stem Cell Institute, Havard University, Cambridge, MA, USA
Dan Ziegler MD, FRCPE
Professor of Internal Medicine, Institute for Clinical Diabetology, German Diabetes Center at the Heinrich Heine University, Leibniz Center for Diabetes Research; Department of Metabolic Diseases, University Hospital, Düsseldorf, Germany
Preface to the Fourth Edition
The management of diabetes is a major health challenge, and its prevalence is increasing at an alarming rate, especially in the developing world. According to the International Diabetes Federation, diabetes currently affects more than 285 million people worldwide, a figure that is expected to rise to 435 million by 2030. During the writing of this book over the last 18 months, approximately 15 million people will have developed diabetes. Although treatments continue to improve, many people die as a result of their diabetes. Between 6–16% of all deaths are attributable to diabetes and around 900 will have died in the 2 hours taken to write this preface. Diabetes accounts for about 6% of total global mortality, on a par with that seen in HIV/AIDS. Many of these deaths will result from cardiovascular disease which occurs at least twice as often in diabetes as in people without diabetes. Diabetes continues to cause suffering through its complications. It is the commonest cause of kidney failure in developed countries where it is also the leading cause of blindness in adults of working age. Diabetes is also a major cause of non-traumatic lower limb amputation. As well as the personal cost, diabetes places a huge burden on health economies. In 2010, it is estimated that worldwide, at least US$ 376 billion will be used to treat and prevent diabetes and its complications. Never have the challenges in providing diabetes healthcare been larger.
During the eight years since the publication of the previous edition of this textbook, there have been great strides in the management and understanding of diabetes. International collaborations using large and varied cohorts with increasingly sophisticated technologies have allowed a greater appreciation of the genetic factors that predispose to diabetes. Our molecular understanding of insulin resistance and the regulation of insulin secretion has increased as has our appreciation of the mechanisms underlying complications.
The diagnostic criteria look set to be changed again and may incorporate hemoglobin A1c (HbA1c) while the units of the latter have also recently changed to reflect the development of more reliable and traceable assays. As HbA1c remains the currency of everyday diabetes practice, these changes will provide major educational challenges for patients and professionals alike.
Alongside the developments in the pathophysiology of diabetes have come major advances in the treatment of diabetes. Some of these therapeutic innovations have been withdrawn, such as inhaled insulin, but many have been adopted in clinical practice. The development of new oral agents to treat type 2 diabetes has diversified choices for clinicians and people with diabetes. Drugs affecting glucagon-like peptide 1 (GLP-1) and the incretin axis that were mentioned briefly as future treatments in the last edition are now firmly established as effective treatments of type 2 diabetes. Many studies have highlighted the advantages and disadvantages of the newer agents making the choice of treatment more complicated than ever. Beyond the gluco-centric view of diabetes, major cardiovascular trials continue to show the benefits of statin therapy in people with diabetes.
The publication of this new edition is timely given the rapid advances in knowledge. This edition has a new editorial team drawn from the UK, Europe, USA and Asia to reflect the global nature of the diabetes epidemic. The new team has experienced a big learning curve and we are profoundly grateful that we could stand on the shoulders of John Pickup and Gareth Williams, the editors of the previous three editions. The new book has retained many of the excellent author team brought together by John and Gareth and the structure is similar to the previous editions. Nevertheless like any new teams we have tried to improve the book while keeping the sound ideas from the previous book. The book has been shortened into one volume to make it easier to use. We have emphasized the clinical aspects of diabetes to a greater extent than previous editions and reflecting the diverse locations of the editors, the chapter authors are also dispersed throughout the globe making this a truly international textbook which crosses continents and highlights both developed and developing health systems.
As editors we are only too aware of the work that many people have contributed to the book, without which our endeavors would have been much harder, if not impossible. The chapter authors are at the top of our list for our gratitude. Their willingness to devote their time and effort into compiling scholarly and relevant chapters, while tolerating nagging e-mails from us, has been humbling. In an age where book writing often comes fourth behind grant and paper writing and clinical work, we are grateful for the way that the authors met the deadlines set by us. We are also grateful for the immense help we have received from our publisher, Wiley-Blackwell. Our Commissioning Editor Oliver Walter, who took over from Alison Brown shortly into the book’s development, has provided encouragement, support and guidance as has Jennifer Seward, the Development Editor. Often just at the time when things appeared to be insurmountable, Oliver or Jennifer took steps to get the project moving again. Our thanks also go to Rob Blundell (Production Editor) and Helen Harvey (Project Manager) in the production team.
We hope you enjoy reading the book and find it useful whether this is helping people with diabetes or teaching physicians and other health professionals how best to manage this disease and its complications.
Richard I.G. Holt
Clive S. Cockram
Allan Flyvbjerg
Barry J. Goldstein
Foreword
The face of diabetes is forever changing. Scientific knowledge increases exponentially and our understanding slowly improves although there are still massive gaps in many fundamental aspects of the diabetes story, such as the mechanisms underlying the development of type 2 diabetes. Trying to keep up with all the advances is an ever increasing burden, but with a large array of means to achieve this. Many people use the web, both specific websites and more general search engines, but there are still a large number of people who prefer the printed word and the collection together of an accessible compendium where you can expect to obtain answers to your questions. This volume provides exactly that; namely a series of up-to-date, well referenced, learned articles covering the manifold manifestations of diabetes together with the basic underlying science. It is truly comprehensive and I would challenge any reader to find missing aspects of the pathophysiology, treatment and care of people with diabetes.
The book begins with a fascinating historical essay which should be read by anybody who picks up the book. It reminds us that much valuable information is forgotten and many lessons can be learned by going back to pre-internet days! The possibility of using HbA1c for the diagnosis of diabetes is discussed reflecting a potentially seismic shift in our diagnostic armamentarium that has relied on the measurement of glucose since that became available routinely a century ago. The world pandemic of diabetes is described with few populations spared and then each type of diabetes is described together with what is known of their pathophysiology. Particularly valuable are the essays on non-classical type 1 and type 2 diabetes.
The management and treatment of diabetes from education through lifestyle modification and the use of oral agents and insulin is dealt with exhaustively with useful chapters on the oft ignored psychological and social aspects of the disorder. Different models of care are also well discussed. Complications are dealt with comprehensively and again the book is of particular value in going beyond the classical complications and dealing with a range of less well defined problems found in people with diabetes. The book finishes with crystal ball gazing: a look at future drugs for both type 1 and type 2 diabetes, as well as the potential for stem cell therapy, islet cell transplantation and gene therapy, all of which are thought provoking and informative.
Overall I feel that this volume fulfils a major need for anyone with an interest in diabetes; it should be available in every setting where people with diabetes receive their care and will serve as an excellent vade mecum.
K. George M.M. Alberti
Imperial College London